Literature DB >> 12860876

Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy?

S R Ommen, R A Nishimura, W D Edwards.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12860876      PMCID： PMC1767790          DOI： 10.1136/heart.89.8.929

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy.

Authors:  A Frustaci; C Chimenti; R Ricci; L Natale; M A Russo; M Pieroni; C M Eng; R J Desnick
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  Enzyme-replacement therapy for Anderson-Fabry disease.

Authors:  G M Pastores; R Thadhani
Journal:  Lancet       Date:  2001-08-25       Impact factor: 79.321

3.  Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.

Authors:  B Sachdev; T Takenaka; H Teraguchi; C Tei; P Lee; W J McKenna; P M Elliott
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

4.  Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

Authors:  R Schiffmann; J B Kopp; H A Austin; S Sabnis; D F Moore; T Weibel; J E Balow; R O Brady
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

5.  An atypical variant of Fabry's disease in men with left ventricular hypertrophy.

Authors:  S Nakao; T Takenaka; M Maeda; C Kodama; A Tanaka; M Tahara; A Yoshida; M Kuriyama; H Hayashibe; H Sakuraba
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245
  5 in total
  14 in total

1.  Fabry disease.

Authors:  S F Nagueh
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

2.  Subaortic membrane mimicking hypertrophic cardiomyopathy.

Authors:  Mark Joseph Anderson; Adelaide Arruda-Olson; Bernard Gersh; Jeffrey Geske
Journal:  BMJ Case Rep       Date:  2015-11-04

Review 3.  The heart in Anderson-Fabry disease and other lysosomal storage disorders.

Authors:  Ales Linhart; Perry M Elliott
Journal:  Heart       Date:  2007-04       Impact factor: 5.994

4.  Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS).

Authors:  Tomas Palecek; Jitka Honzikova; Helena Poupetova; Hana Vlaskova; Petr Kuchynka; Lubor Golan; Sudheera Magage; Ales Linhart
Journal:  J Inherit Metab Dis       Date:  2013-10-31       Impact factor: 4.982

5.  Fabry disease: incidence of the common later-onset α-galactosidase A IVS4+919G→A mutation in Taiwanese newborns--superiority of DNA-based to enzyme-based newborn screening for common mutations.

Authors:  Yin-Hsiu Chien; Ni-Chung Lee; Shu-Chuan Chiang; Robert J Desnick; Wuh-Liang Hwu
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

6.  Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease.

Authors:  Rodolfo Citro; Costantina Prota; Donatella Ferraioli; Giuseppe Iuliano; Michele Bellino; Ilaria Radano; Angelo Silverio; Serena Migliarino; Maria Vincenza Polito; Artemisia Ruggiero; Rosa Napoletano; Vincenzo Bellizzi; Michele Ciccarelli; Gennaro Galasso; Carmine Vecchione
Journal:  Front Cardiovasc Med       Date:  2022-04-25

Review 7.  The genetics of hypertrophic cardiomyopathy.

Authors:  Mohammed Akhtar; Perry Elliott
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

8.  High Prevalence of Late-Onset Fabry Cardiomyopathy in a Cohort of 499 Non-Selective Patients with Left Ventricular Hypertrophy: The Asian Fabry Cardiomyopathy High-Risk Screening Study (ASIAN-FAME).

Authors:  Yiting Fan; Tsz-Ngai Chan; Josie T Y Chow; Kevin K H Kam; Wai-Kin Chi; Joseph Y S Chan; Erik Fung; Mabel M P Tong; Jeffery K T Wong; Paul C L Choi; David K H Chan; Bun Sheng; Alex Pui-Wai Lee
Journal:  J Clin Med       Date:  2021-05-17       Impact factor: 4.241

9.  Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy.

Authors:  Martina Gaggl; Natalija Lajic; Georg Heinze; Till Voigtländer; Raute Sunder-Plassmann; Eduard Paschke; Günter Fauler; Gere Sunder-Plassmann; Gerald Mundigler
Journal:  Int J Med Sci       Date:  2016-04-26       Impact factor: 3.738

10.  Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy.

Authors:  Woo-Shik Kim; Hyun Soo Kim; Jinho Shin; Jong Chun Park; Han-Wook Yoo; Toshihiro Takenaka; Chuwa Tei
Journal:  J Korean Med Sci       Date:  2019-02-15       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.